Editorial comment: Evidence exists for neuroanatomical abnormalities in diabetic penile tissue but the physiological correlates of these ®ndings have not been well demonstrated. These investigators have identi®ed that the spontaneously diabetic BioBreeding Wistar (BB/WOR) rat strain lacks confounding vasculopathic changes and thus it provides a useful model to investigate the possible involvement of alternative etiologies in the erectile dysfunction of diabetes. This report represents a rigorous evaluation of behavioural, endocrinological, and neurophysiological variables pertaining to sexual dysfunction in this rat model. Copulatory behavioural testing demonstrated severe impairment in the diabetic rats, consistent with previous reports. Contrary to earlier reports, there was no measurable androgen de®ciency in the diabetic rats of this study, and the investigators discount the possibility of androgen defects as the cause for sexual dysfunction in this model. Most interestingly, nerve conduction velocity, sexual re¯ex and urethrogenital re¯ex experiments in the diabetic animals revealed signi®-cant de®cits. An important component of this neurophysiological assessment was the study of urethrogenital re¯exes, which precisely evaluated the integrity of central neurophysiological mechanisms. Because of de®cits in these particular re¯exes in the diabetic rats, the investigators introduce the role of a primary central neuropathic process in the sexual dysfunction of this model and suggest its likely involvement in the pathogenesis of diabetic sexual dysfunction in general. This work establishes the importance of central and peripheral neuropathic processes in diabetic sexual dysfunction although further investigation is necessary to de®ne the relative contributions of these processes and vasculopathic consequences to this dysfunction.
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Diminished neurogenic but not pharmacological erections in the 2-to 3-month experimentally diabetic F-344 rat J Rehman, E Chenven, P Brink, B Peterson, B Walcott, Editorial comment: It has become increasingly clear that a full understanding of erection physiology at the peripheral organ level requires that one recognize the integrative functions of all regulatory components, which are required for the initiation and transmission of the erectile stimulus. These components include neuronal pathways, intracellular signal transduction mechanisms, and intercellular communication systems. These investigators strategically examine these components in an in vivo experimentally induced diabetic rat model. They found that penile re¯exes and electrically stimulated erections were altered in the diabetic animals, which suggests the apparent role of autonomic neuropathy in the erectile dysfunction of diabetes. In support of this conclusion, the investigators showed decreased immunoreactivity for synaptophysin, a marker of presynaptic nerve terminals, in the corporal tissue of diabetic rats. On the other hand, pharmacologically stimulated erections were preserved in the diabetic animals, indicting that corporal smooth muscle cells in the diabetic penis maintain biochemical responsiveness to neurotransmitter stimulation. Finally, connexin 43 (the primary gap junction channel protein) was found to have increased mRNA expression in the corporal tissue of diabetic rats, leading the investigators to speculate that the tissue is attempting to``compensate'' for the loss of neuronal innervation by ensuring better coupling among smooth muscle cells. These data promote concepts that the erectile dysfunction of diabetes occurring at the peripheral level results from derangements in the release and possibly in the interactions of chemical (neural, hormonal, and paracrine) effectors and is accompanied by changes in intercellular communication. As future investigations are undertaken to elucidate the pathophysiology of the erectile dysfunction of diabetes as well as of other disease states, proper perspective should be given to all physiological components which may impact on the production of the erectile response. (NOS) and an inducible NOS cDNA construct delivered to the corporal tissue of aged rats, they have shown an amelioration of aging-associated erectile dysfunction with measurement of erectile responses to electrical stimulation. As such, the investigators have offered an initial report on gene transfer to the penis as a therapy for erectile dysfunction. The feasibility of this approach has been shown, although further scienti®c strides are necessary to develop control operations that will allow this therapy to be practically delivered and achieve the intended physiological effect in the corporal tissue without producing undesirable adverse effects such as priapism or structural damage.
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